Business Context and Reporting Period
This Form 8-K Current Report was filed by Twin Vee PowerCats Co. on July 2, 2024, covering events occurring on June 26 and June 27, 2024. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol VEEE.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on executive compensation adjustments and equity grants.
Material Changes and Executive Actions
- Salary Increase: An amendment to the employment agreement for Preston Yarborough (Vice President) was executed on June 27, 2024, effective July 23, 2021, increasing his base salary to $200,000.
- Stock Option Grants (June 26, 2024):
- Mike Dickerson (CFAO): 100,000 shares at an exercise price of $0.57.
- Preston Yarborough (VP): 200,000 shares at an exercise price of $0.57.
- Joseph Visconti (Chairman & CEO): 300,000 shares at an exercise price of $0.57.
- Stock Option Grant (June 27, 2024):
- Mike Dickerson (CFAO): 50,000 shares at an exercise price of $0.53.
Terms, Outlook, and Risks
Option Terms:
- Options granted to Mr. Yarborough and Mr. Visconti vest pro rata monthly over two years and expire ten years from the grant date.
- Options granted to Mr. Dickerson vest pro rata annually over four years and expire ten years from the grant date.
- All grants were made pursuant to the Company's amended and restated 2021 Stock Incentive Plan.
Management Commentary and Risks: The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of material risks and contingencies beyond the standard incorporation of the employment amendment by reference.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2021 Stock Incentive Plan to assess remaining capacity for future grants.
- Review the full text of the Yarborough Amendment (Exhibit 10.1) for additional compensation terms or conditions not summarized in the filing.
- Confirm the vesting schedules and exercise prices against the company's most recent proxy statement or equity compensation plan disclosure.
- Monitor the impact of these grants on potential dilution to existing shareholders.